| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 02/23/2011 | CN101978990A Schisandra extract and preparation method and application thereof |
| 02/23/2011 | CN101978989A Chinese medicament for treating diabetic diarrhea |
| 02/23/2011 | CN101978985A Medicament for treating periodontal pocket and sinus |
| 02/23/2011 | CN101978984A Method for preparing large-head atractylodes rhizome and sesquiterpene compound |
| 02/23/2011 | CN101978981A Medicinal composition for treating oral ulcer and preparation method thereof |
| 02/23/2011 | CN101978977A Self-emulsifying brucea javanica oil oral preparation composition and preparation method thereof |
| 02/23/2011 | CN101978961A Composition for treating gingivitis or peridentitis and application thereof |
| 02/23/2011 | CN101978952A Method for preparing berberine hydrochloride liposome preparation |
| 02/23/2011 | CN101978951A 9,10-diphenylanthracene(DPA) ester fat emulsion intravenous injection and manufacturing method thereof |
| 02/23/2011 | CN101978910A Snake bee nano-selenium element Chinese medicinal anion far infrared multi-functional navel-warming bag shorts |
| 02/23/2011 | CN101978852A Microbial feed additive for treating piglet yellow and white dysentery and preparation method thereof |
| 02/23/2011 | CN101417054B Traditional Chinese medicine composite for treating dizziness |
| 02/22/2011 | USRE42164 Hepatitis C inhibitor tri-peptides |
| 02/22/2011 | US7893279 Cyclohexanecarboxylic acid compound |
| 02/22/2011 | US7893204 Attractin/mahogany-like polypeptides |
| 02/22/2011 | US7893090 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 02/22/2011 | US7893087 3(R)-1-Phenethyl-(9[H]-xanthene-9-carbonyloxy)-1-azoniabicyclo[2.2.2] octane quaternary salt with a mono- or polyvalent anion; antimuscarinic agents used to treat chronic obstructive pulmonary disease, chronic bronchitis, bronchial hyperreactivity, asthma, or rhinitis |
| 02/22/2011 | US7893036 In vivo production of small interfering RNAs that mediate gene silencing |
| 02/22/2011 | US7892754 Hepatitis B virus pre-S1 derived synthetic polypeptides and uses thereof |
| 02/22/2011 | US7892582 Composition for oral administration containing capsaicinoids |
| 02/22/2011 | US7892531 Human serum albumin(HSA); solubilized in low-ionic-strength buffer with specified ph; glycine, aspartic acid, sodium succinate, trehalose; binds with receptors |
| 02/22/2011 | CA2486378C Preparation and application of total salvianolic acid |
| 02/22/2011 | CA2476296C Amino-derivatives as inhibitors of histone deacetylase |
| 02/22/2011 | CA2470575C Spiroazacyclic compounds as monoamine receptor modulators |
| 02/22/2011 | CA2466726C Preparation composition containing acid-unstable physiologically active compound and process for producing same |
| 02/22/2011 | CA2411818C Cyclopentabenzofuran compounds and uses thereof |
| 02/22/2011 | CA2410193C Neuronal serine-threonine protein kinase |
| 02/22/2011 | CA2403139C Novel 1-[1-(hetero)aryl-1-perhydroxyalkylmethyl]-piperazine compounds, process for their preparation and medicaments containing these compounds |
| 02/22/2011 | CA2170644C Multiple unit pharmaceutical preparation containing proton pump inhibitor |
| 02/22/2011 | CA2137221C Preparation of 3,4,4-trisubstituted piperidinyl-n-alkylcarboxylates and intermediates |
| 02/17/2011 | WO2011020095A2 Compositions and methods of treating inflammation |
| 02/17/2011 | WO2011020054A1 Method for modulating the pharmacodynamic effect of orally administered guanylate cyclase receptor agonists |
| 02/17/2011 | WO2011019210A2 Dietary supplement, feed and pharmaceutical composition containing chia seed and maca, and preparation method thereof |
| 02/17/2011 | WO2011019043A1 Tablet that disintegrates rapidly in the mouth and that contains two or more types of particles |
| 02/17/2011 | WO2010122980A8 NOVEL THYROID HORMONE β RECEPTOR AGONIST |
| 02/17/2011 | WO2010046289A3 Blockers of light, ltalpha1beta2 and ltalpha2beta1 or their receptor ltbetar for the prevention and treatment of chronic hepatitis and other liver diseases |
| 02/17/2011 | US20110039930 Fast-acting naproxen composition with reduced gastrointestinal effects |
| 02/17/2011 | US20110039926 Use of enantiomer (1s, 2r) milnacipran hydrochloride for the preventive treatment of suicidal behaviour in depressed patients |
| 02/17/2011 | US20110039920 Inhibitors of ikk-beta serine-theronine protein kinase |
| 02/17/2011 | US20110039919 Pharmaceutical compositions for inhibiting angiogenesis |
| 02/17/2011 | US20110039888 Asymmetric alpha functionalization and alpha, alpha bisfunctionalization of aldehydes and ketones |
| 02/17/2011 | US20110039887 Carbostyril derivatives including cilostazol for treating fatty liver |
| 02/17/2011 | US20110039877 Use of 3, 11b-cis-dihydrotetrabenazine in the treatment of multiple sclerosis and autoimmune myelitis |
| 02/17/2011 | US20110039874 Monoacylglycerol lipase inhibitors for modulation of cannabinoid activity |
| 02/17/2011 | US20110039862 Protease Inhibitors |
| 02/17/2011 | US20110039858 Novel Compounds |
| 02/17/2011 | US20110039824 1,2,3,6-tetrahydroazepino[4,5-b]indole-5-carboxylate nuclear receptor inhibitors |
| 02/17/2011 | US20110039800 Prolonged release bioadhesive therapeutic systems |
| 02/17/2011 | US20110039786 Metastin derivative and use thereof |
| 02/17/2011 | US20110039781 Treatment of Conditions Related to Cecal Ligation Shock |
| 02/17/2011 | US20110039757 Agonists of Bitter Taste Receptors and Uses Thereof |
| 02/17/2011 | US20110038966 Use of a potent product extracted from rhizomes of zingiber officinale in treating a disease associated with helicobacter pylori |
| 02/17/2011 | US20110038956 Selenium-containing compositions and uses thereof |
| 02/17/2011 | US20110038955 Prevention of gastric ulcer by carbon monoxide |
| 02/17/2011 | US20110038945 Orally ingestable medicament and method for treating a heartburn inducing event or an acid reflux episode in a living human subject |
| 02/17/2011 | US20110038944 Compositions and methods for diagnosis and treatment of hepatobiliary disease and associated disorders |
| 02/17/2011 | US20110038933 Stable benzimidazole formulation |
| 02/17/2011 | US20110038925 Intravenous formulations of neurokinin-1 antagonists |
| 02/17/2011 | US20110038921 Methods and compositions for temporal release of agents from a biodegradable scaffold |
| 02/17/2011 | US20110038913 Polymeric endoprostheses with modified erosion rates and methods of manufacture |
| 02/17/2011 | US20110038896 Biodegradable immunomodulatory formulations and methods for use thereof |
| 02/17/2011 | US20110038882 Methods for Treating Allergic Disease |
| 02/17/2011 | US20110038838 Probiotic enhancement of steroid and immune suppressor activity in mammals with chronic diseases |
| 02/17/2011 | US20110038837 Composition for improving intestinal microflora |
| 02/17/2011 | US20110038829 Methods and materials for treating diarrhea |
| 02/17/2011 | US20110038809 Growth control of oral and superficial microorganisms using gallium compounds |
| 02/17/2011 | CA2771283A1 Nutritional compositions including exogenous nucleotides |
| 02/17/2011 | CA2770403A1 Intravenous formulations of neurokinin-1 antagonists |
| 02/17/2011 | CA2770211A1 Methods for iontophoretically treating nausea and migraine |
| 02/16/2011 | EP2284189A2 Nucleic acid molecules encoding fibroblast growth factor-like (FGF-like) polypeptides |
| 02/16/2011 | EP2283897A2 HSA-free formulations of interferon-beta |
| 02/16/2011 | EP2283896A2 HSA-free formulations of interferon-beta |
| 02/16/2011 | EP2283867A2 Methods of treatment using anti-ERBB antibody-maytansinoid conjugates |
| 02/16/2011 | EP2283866A2 Methods of treatment using anti-ERBB antibody-maytansinoid conjugates |
| 02/16/2011 | EP2283855A2 Polypeptides et polynucleotides de phorphorymonas gingivalis |
| 02/16/2011 | EP2283854A2 Porphorymonas gingivalis polypeptides and polynucleotides |
| 02/16/2011 | EP2283853A2 Porphorymonas gingivalis polypeptides and polynucleotides |
| 02/16/2011 | EP2283852A2 Porphorymonas gingivalis polypeptides and polynucleotides |
| 02/16/2011 | EP2283835A2 Method and preparation for treating metabolic stress |
| 02/16/2011 | EP2283833A2 Amines and amides for the treatment of diseases |
| 02/16/2011 | EP2283832A1 Compositions comprising cannabinoids for treatment of nausea, vomiting, emesis, motion sickness or like conditions |
| 02/16/2011 | EP2283130A1 DISPERSINBtm, 5-FLUOROURACIL, DEOXYRIBONUCLEASE I AND PROTEINASE K-BASED ANTIBIOFILM COMPOSITIONS AND USES THEREOF |
| 02/16/2011 | EP2283008A2 Pyrrole derivatives, preparation of same and therapeutic application thereof |
| 02/16/2011 | EP2283007A2 Pyrrole derivatives, preparation of same and therapeutic application thereof |
| 02/16/2011 | EP2282741A2 Treating eosinophilic esophagitis |
| 02/16/2011 | EP2282648A2 Prebiotic composition and methods of making and using the same |
| 02/16/2011 | EP1890558B1 Food products containing laminarin |
| 02/16/2011 | EP1835021B1 Novel strain conferring anti-disease properties to host and bacterial cell composition |
| 02/16/2011 | EP1469077B1 Cell-specific expression/replication vector |
| 02/16/2011 | EP1455794B1 ClC-2 CHANNEL OPENER FOR TREATING GASTRIC OR BOWEL ULCER |
| 02/16/2011 | CN1994385B Externally applied Chinese medicinal effervescence tablet for fumigating and washing to treat external piles and anal fissure and method for preparing same |
| 02/16/2011 | CN1913910B Composition comprising hovenia dulcis thunb. extract, lindera obtusiloba blume extract, or herbal mixture extract thereof |
| 02/16/2011 | CN101977619A Soluble complexes of curcumin |
| 02/16/2011 | CN101977614A Method for decreasing abdominal girth by administering a bifidobacterium bacteria |
| 02/16/2011 | CN101977610A Methods of treating viral infections |
| 02/16/2011 | CN101977599A Composition of aqueous buffer solution for the treatment of cellular environment and ion channels and methods for using same |
| 02/16/2011 | CN101974529A TGF-beta specific siRNA containing free triphosphoric acid group and application thereof |
| 02/16/2011 | CN101974480A Liver engrafting cells, assays, and uses thereof |
| 02/16/2011 | CN101974397A Healthcare wine and preparation method thereof |
| 02/16/2011 | CN101974392A Preparation method of ginseng flower active liquor |